In last trading session, NewAmsterdam Pharma Company NV (NASDAQ:NAMS) saw 0.57 million shares changing hands with its beta currently measuring -0.06. Company’s recent per share
During the last session, NewAmsterdam Pharma Company NV (NASDAQ:NAMS)’s traded shares were 0.74 million, with the beta value of the company hitting -0.06. At the
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
